Healthcare -
Biotechnology - NASDAQ - US
$ 15.12
1.96 %
$ 614 M
Market Cap
-88.88
P/E
KROS - CASH FROM OPERATIONS
Cash from Operations KROS - Keros Therapeutics, Inc.
-161 M
LAST VALUE
-51.53%
2 YEAR CAGR
-58.67%
5 YEAR CAGR
0.00%
10 YEAR CAGR